Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

HARTE HANKS INC Director's Dealing 2018

Aug 29, 2018

34832_dirs_2018-08-29_e65262ca-e60a-46a3-b0ce-f888366b4c47.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: HARTE HANKS INC (HHS)
CIK: 0000045919
Period of Report: 2018-08-28

Reporting Person: KEARNES LAURILEE (Vice President and Controller)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $ Common Stock (2364.0) Direct
Restricted Stock Units $ Common Stock (2025.0) Direct

Footnotes

F1: Includes (i) options to purchase 63 shares of common stock at $60.40 pursuant to a grant made on February 5, 2009, which fully vested on February 5, 2013 and expires on February 5, 2019, (ii) options to purchase 250 shares of common stock at $119.00 pursuant to a grant made on February 5, 2010, which fully vested on February 5, 2014 and expires on February 5, 2020, (iii) options to purchase 200 shares of common stock at $123.10 pursuant to a grant made on February 5, 2011, which fully vested on February 5, 2015 and expires on February 5, 2021, (iv) options to purchase 300 shares of common stock at $99.10 pursuant to a grant made on February 5, 2012, which fully vested on February 5, 2016 and expires on February 5, 2022, (v) options to purchase 400 shares of common stock at $77.20 pursuant to a grant made on February 5, 2013, which fully vested on February 5, 2017 and expires on February 5, 2023.

F2: Includes (i) options to purchase 297 shares of common stock at $82.30 pursuant to a grant made on April 15, 2014, which fully vested on April 15, 2018 and expires on April 15, 2024, and (ii) options to purchase 854 shares of common stock at $76.80 pursuant to a grant made on April 15, 2015, which vests in four equal installments on each of the first four anniversaries of the grant and expires on April 15, 2025.

F3: Includes (i) 465 shares of phantom stock granted on April 15, 2016 which vests in four equal installments on each of the first four anniversaries of the grant and (ii) 1,560 shares of phantom stock granted on June 23, 2017 which vests in four equal installments on each of the first four anniversaries of the grant. Each share of phantom stock is the economic equivalent of one share of Issuer's common stock.